NCT07716865: Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
- State
- Under way
- Phase
- Phase 2
- People
- 15 taking part
- Started
- 3 Apr 2024
- Primary completion
- 29 Dec 2026
- Arms
- Landspitali University Hospital
- Results
- None posted
- 3 Apr 2024: Trial started
- 21 Jul 2026: Trial registered